In a study of 100 patients with SLE and 74 patients with various neurologic disorders, more SLE patients comparing to neurologic injury/disease control patients have presence of anti-MAP-2 antibodies (17% vs. 4%, p=0.028 ) [65]. Here, MAP2 is linked to systemic lupus erythematosus.